46 /100
MEDIUM RISK
Score updated May 30, 2026

BTCS — BTCS Inc. Dilution Risk Tracker

Track BTCS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BTCS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
38%
🔁 Convertible Conversion 40%
• Significant convertible debt: 16% potential dilution
• Elevated convertible risk (60/100)
📉 Score Deterioration 40%
• Score rose 28 points recently (worsening)
🔄 Reverse Split 30%
• 50-day avg $1.76 approaching $1 threshold
🔔 Track BTCS — Get forecast alerts →

💹 Market Data

Market Cap$78.15M
Shares Outstanding49.78M
Float38.23M
Cash$1.53M
Debt$73.34M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 83.1% shares (2025Q4 vs prior)
59 institutional holders · 11.15M shares
#1 STATE STREET CORP 2.53M shares
#2 VANGUARD GROUP INC 2.01M shares
#3 GEODE CAPITAL MANAGEMENT, LLC 1.16M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.66M
Days to Cover2.3
% of Float7.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026
xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track BTCS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BTCS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BTCS
📊 BTCS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BTCS Signal Convergence & Dark Pool Activity — StonkWhisper 📄 BTCS Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.